# Cagrilintide vs Eloralintide: How They Differ | PepVault

Source: https://pepvault.app/peptides/compare/cagrilintide-vs-eloralintide

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Library](https://pepvault.app/peptides) [Comparisons](https://pepvault.app/peptides/compare) Cagrilintide vs Eloralintide

Compared side by side

# Cagrilintide vs eloralintide: how they differ

Reviewed November 2026 [How we check the library](https://pepvault.app/about#library) [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The short answer

Both are weekly amylin drugs, built differently: cagrilintide acts on amylin receptors and on the calcitonin receptor, while eloralintide, from Eli Lilly, acts far more on amylin receptors than on the calcitonin receptor, and its half-life of about 14 days keeps levels nearly flat across the week. Neither is approved: cagrilintide is the amylin half of Novo Nordisk’s CagriSema, and eloralintide has been in phase 3 since late 2025. On their own, cagrilintide’s higher doses led to about 10–12% weight loss in trials, and eloralintide’s ran from about 9.5% on 1 mg to about 20% on 9 mg at 48 weeks in phase 2.

## Side by side

| Compared | [Cagrilintide](https://pepvault.app/peptides/cagrilintide) | [Eloralintide](https://pepvault.app/peptides/eloralintide) |
| --- | --- | --- |
| Category | Metabolic & GLP-1 | Metabolic & GLP-1 |
| Also known as | Cagri, AM833, NNC0174-0833 | LY3841136, Elora |
| What it is | A long-acting version of amylin, the fullness hormone the pancreas releases alongside insulin, given as a weekly shot. | A once-weekly amylin drug from Eli Lilly, built to copy the fullness hormone the pancreas releases with insulin, and to act on its receptor more selectively than cagrilintide does. |
| How it works | Long-acting, lipidated analogue of amylin, the satiety hormone the pancreas releases with insulin. It activates amylin receptors and the calcitonin receptor (a non-selective amylin agonist); amylin promotes fullness, slows stomach emptying and holds back glucagon after meals. A fatty-acid chain stretches its half-life to about a week, so it is a weekly shot, usually run beside a GLP-1. Not approved on its own: it is the amylin half of Novo Nordisk's CagriSema. | Once-weekly, long-acting agonist of the amylin receptor, the receptor for amylin, the fullness hormone the pancreas releases with insulin. Unlike cagrilintide, it is selective: it acts far more on amylin receptors than on the calcitonin receptor, a difference Lilly thinks may make it easier on the stomach. The idea is fewer calories through earlier fullness after meals rather than through the GLP-1 pathway. Its half-life of about 14 days keeps blood levels nearly flat across the week. Investigational, from Eli Lilly, in phase 3 since late 2025. |
| Commonly reported | Feeling full sooner and portions shrinking, with nausea or constipation after step-ups and some injection-site reactions. It is not approved on its own. | In trials, fewer cravings, especially for sugar, and less food noise, with nausea and tiredness more likely on the higher doses. It is in phase 3 and not approved anywhere. |
| Studied range | Research range: 0.25–2.4 mg, starting dose 0.25 mg. Studied in research — not a recommendation. | Research range: 1–9 mg, starting dose 3 mg. Studied in research — not a recommendation. |
| How often | Weekly | Weekly |
| Half-life | ~1 week (measured in people: 159–195 hours in a phase 1b trial) | ~14 days (measured in people: phase 1 trials, Bhattachar 2026) |
| Route | SubQ injection | SubQ injection |
| Typical run | Trials run it continuously: 26 weeks in phase 2, 68 weeks in phase 3. Community use is mostly as a weekly add-on to a GLP-1. | Used continuously, once weekly, in its trials: 12 weeks in phase 1 and 48 weeks in phase 2; phase 3 runs about 75 weeks. No trial has tested stopping it. |
| Evidence | Established: clinical trials or FDA-approved use exists | Moderate: animal studies + some human data |
| Common side effects | Nausea, constipation, diarrhea, injection-site reactions | Nausea, fatigue, constipation, diarrhea, vomiting, decreased appetite, hair thinning, injection site reaction |

Typical run: Community practice — opinions vary. Not a clinical recommendation.

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking cagrilintide or eloralintide? Log it in PepVault

Each dose, each vial and your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=compound-vs-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## Week by week

Each entry’s cards by day window, as the compound pages show them. Day 1 is the day you start it.

### Cagrilintide

- Day 1–28 · 0.25 mg The 0.25 mg start
- Day 29–364 · 0.5 mg 0.5 mg, the second step
- Day 57–364 · 1 mg 1 mg, the middle step
- Day 85–364 · 1.7 mg 1.7 mg, the step before 2.4 mg
- Day 113+ · 2.4 mg 2.4 mg, the phase 3 dose

[Every card for cagrilintide, with its sources](https://pepvault.app/peptides/cagrilintide#weeks)

### Eloralintide

- Day 1–28 · 3 mg Fullness first, gently
- Day 29–56 · 6 mg The step where nausea shows up
- Day 57–336 · 6 mg Holding at 6 mg
- Day 57–336 · 9 mg The top dose tested
- Day 85–336 Fewer cravings, quieter food noise
- Day 337+ A long-term medicine, not a course

[Every card for eloralintide, with its sources](https://pepvault.app/peptides/eloralintide#weeks)

## With this comparison

### Cagrilintide

- [Cagrilintide: the full reference](https://pepvault.app/peptides/cagrilintide)
- [Cagrilintide dose guide](https://pepvault.app/lab/dosage/cagrilintide)

### Eloralintide

- [Eloralintide: the full reference](https://pepvault.app/peptides/eloralintide)
- [Eloralintide dose guide](https://pepvault.app/lab/dosage/eloralintide)

### Mixing charts

- [Cagrilintide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/cagrilintide-5mg)
- [Cagrilintide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/cagrilintide-10mg)
- [Eloralintide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/eloralintide-10mg)

### Studies

- [CagriSema: 30.3% hit both BMI and waist-to-height targets at 68 weeks](https://pepvault.app/research/cagrilintide-redefine-1-2026)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 7 studies](https://pepvault.app/research#cagrilintide)
- [Eloralintide: 2.6% to 11.3% weight loss at 12 weeks in phase 1](https://pepvault.app/research/eloralintide-bhattachar-2026)
- [Eloralintide: -4.4% body weight at week 4 in a single-dose trial](https://pepvault.app/research/eloralintide-briere-2025)
- [All 2 studies](https://pepvault.app/research#eloralintide)

### Compared with

- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Retatrutide vs Cagrilintide](https://pepvault.app/peptides/compare/retatrutide-vs-cagrilintide)
- [Tirzepatide vs Cagrilintide](https://pepvault.app/peptides/compare/tirzepatide-vs-cagrilintide)
- [Cagrilintide vs Pramlintide](https://pepvault.app/peptides/compare/cagrilintide-vs-pramlintide)
- [Cagrilintide vs Petrelintide](https://pepvault.app/peptides/compare/cagrilintide-vs-petrelintide)
- [Eloralintide vs Petrelintide](https://pepvault.app/peptides/compare/eloralintide-vs-petrelintide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Subcutaneous (SubQ)](https://pepvault.app/glossary/subcutaneous)
- [Half-life](https://pepvault.app/glossary/half-life)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Glucagon](https://pepvault.app/glossary/glucagon)

## Questions people ask

### How long do cagrilintide and eloralintide last?

The half-life of cagrilintide is ~1 week (measured in people: 159–195 hours in a phase 1b trial). The half-life of eloralintide is ~14 days (measured in people: phase 1 trials, Bhattachar 2026).

### How often are cagrilintide and eloralintide taken?

Cagrilintide: weekly. Route: SubQ injection. Eloralintide: weekly. Route: SubQ injection.

### How are cagrilintide and eloralintide dosed in research?

The research range for cagrilintide is 0.25–2.4 mg, with a 0.25 mg starting dose. The research range for eloralintide is 1–9 mg, with a 3 mg starting dose. Studied in research — not a recommendation.

### What are the common side effects of cagrilintide and eloralintide?

For cagrilintide, the library lists: nausea, constipation, diarrhea, injection-site reactions. For eloralintide: nausea, fatigue, constipation, diarrhea, vomiting, decreased appetite, hair thinning, injection site reaction.

## Each one in full

- [Cagrilintide: dosage, half-life & reference guide](https://pepvault.app/peptides/cagrilintide)
- [Eloralintide: dosage, half-life & reference guide](https://pepvault.app/peptides/eloralintide)
- [Cagrilintide dose guide](https://pepvault.app/lab/dosage/cagrilintide)
- [Eloralintide dose guide](https://pepvault.app/lab/dosage/eloralintide)

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=compound-vs-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking cagrilintide or eloralintide? Log it in PepVault

Each dose, each vial and your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=compound-vs-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking cagrilintide or eloralintide? Log it in PepVault

Each dose, each vial and your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=compound-vs-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this comparison

### Cagrilintide

- [Cagrilintide: the full reference](https://pepvault.app/peptides/cagrilintide)
- [Cagrilintide dose guide](https://pepvault.app/lab/dosage/cagrilintide)

### Eloralintide

- [Eloralintide: the full reference](https://pepvault.app/peptides/eloralintide)
- [Eloralintide dose guide](https://pepvault.app/lab/dosage/eloralintide)

### Mixing charts

- [Cagrilintide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/cagrilintide-5mg)
- [Cagrilintide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/cagrilintide-10mg)
- [Eloralintide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/eloralintide-10mg)

### Studies

- [CagriSema: 30.3% hit both BMI and waist-to-height targets at 68 weeks](https://pepvault.app/research/cagrilintide-redefine-1-2026)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 7 studies](https://pepvault.app/research#cagrilintide)
- [Eloralintide: 2.6% to 11.3% weight loss at 12 weeks in phase 1](https://pepvault.app/research/eloralintide-bhattachar-2026)
- [Eloralintide: -4.4% body weight at week 4 in a single-dose trial](https://pepvault.app/research/eloralintide-briere-2025)
- [All 2 studies](https://pepvault.app/research#eloralintide)

### Compared with

- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Retatrutide vs Cagrilintide](https://pepvault.app/peptides/compare/retatrutide-vs-cagrilintide)
- [Tirzepatide vs Cagrilintide](https://pepvault.app/peptides/compare/tirzepatide-vs-cagrilintide)
- [Cagrilintide vs Pramlintide](https://pepvault.app/peptides/compare/cagrilintide-vs-pramlintide)
- [Cagrilintide vs Petrelintide](https://pepvault.app/peptides/compare/cagrilintide-vs-petrelintide)
- [Eloralintide vs Petrelintide](https://pepvault.app/peptides/compare/eloralintide-vs-petrelintide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Subcutaneous (SubQ)](https://pepvault.app/glossary/subcutaneous)
- [Half-life](https://pepvault.app/glossary/half-life)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Glucagon](https://pepvault.app/glossary/glucagon)

<!--promo-->

PepVault for iPhone

## Taking cagrilintide or eloralintide? Log it in PepVault

Each dose, each vial and your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=compound-vs-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## More comparisons

- [All peptide comparisons](https://pepvault.app/peptides/compare)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Retatrutide vs Cagrilintide](https://pepvault.app/peptides/compare/retatrutide-vs-cagrilintide)
- [Tirzepatide vs Cagrilintide](https://pepvault.app/peptides/compare/tirzepatide-vs-cagrilintide)
- [Cagrilintide vs Pramlintide](https://pepvault.app/peptides/compare/cagrilintide-vs-pramlintide)
- [Cagrilintide vs Petrelintide](https://pepvault.app/peptides/compare/cagrilintide-vs-petrelintide)
- [Eloralintide vs Petrelintide](https://pepvault.app/peptides/compare/eloralintide-vs-petrelintide)

## The library

- [The peptide reference library](https://pepvault.app/peptides)
- [Metabolic & GLP-1 peptides](https://pepvault.app/peptides#metabolic)

## Free tools

- [The Dose Guide](https://pepvault.app/lab/dosage)
- [Half-life & active level](https://pepvault.app/tools/peptide-half-life-calculator)
- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
